JAZZ Competitors & Alternatives
Compare Jazz Pharmaceuticals PLC with similar stocks in the same industry
Biotechnology
JAZZ
Main Stock$233.01
Tradestie Score
61
Market Cap
$8.30B
P/E Ratio
15.8
Revenue Growth
0.2%
Analyst Upside
+25.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$34.55
|
$19.56B | 28.1 | 42 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.14
|
$16.93B | 15.2 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.63
|
$15.70B | 31.4 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$140.71
|
$13.59B | 21.3 | 54 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.31
|
$12.36B | 17.9 | 69 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.50
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$188.94
|
$10.74B | - | 36 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.44
|
$10.53B | 162.2 | 59 | Compare |
More JAZZ Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry